Indication
Infant botulism
Infant botulism is a neuroparalytic disease occurring in infants—predominantly those under six months of age—caused by intestinal colonization with *Clostridium botulinum* spores and subsequent in vivo neurotoxin production. Read more about Infant botulism
1 drugs 1 manufacturers
Drugs that treat it
Common Infant botulism therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonInfant botulism is a neuroparalytic disease occurring in infants—predominantly those under six months of age—caused by intestinal colonization with *Clostridium botulinum* spores and subsequent in vivo neurotoxin production.
The absorbed botulinum neurotoxin irreversibly inhibits acetylcholine release at peripheral cholinergic synapses and neuromuscular junctions.
Clinically, it is characterized by an initial onset of constipation followed by symmetric, descending flaccid paralysis.
This typically manifests as bulbar palsies, weak cry, poor feeding, diminished suck and gag reflexes, ptosis, generalized hypotonia, and potentially fatal respiratory failure.
- cdc.gov
Infant botulism is a neuroparalytic disease occurring in infants—predominantly those under six months of age—caused by intestinal colonization with *Clostridium botulinum* spores and subsequent in vivo neurotoxin production Clinically, it is characterized by an initial onset of constipation followed by symmetric, descending flaccid paralysis This typically manifests as bulbar palsies, weak cry, poor feeding, diminished suck and gag reflexes, ptosis, generalized hypotonia, and potentially fatal r...
- nih.gov
Infant botulism is a neuroparalytic disease occurring in infants—predominantly those under six months of age—caused by intestinal colonization with *Clostridium botulinum* spores and subsequent in vivo neurotoxin production The absorbed botulinum neurotoxin irreversibly inhibits acetylcholine release at peripheral cholinergic synapses and neuromuscular junctions
- merckmanuals.com
Infant botulism is a neuroparalytic disease occurring in infants—predominantly those under six months of age—caused by intestinal colonization with *Clostridium botulinum* spores and subsequent in vivo neurotoxin production Clinically, it is characterized by an initial onset of constipation followed by symmetric, descending flaccid paralysis This typically manifests as bulbar palsies, weak cry, poor feeding, diminished suck and gag reflexes, ptosis, generalized hypotonia, and potentially fatal r...
- aafp.org
The absorbed botulinum neurotoxin irreversibly inhibits acetylcholine release at peripheral cholinergic synapses and neuromuscular junctions
Personalize your experience
Follow Infant botulism and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.